Inventor · disambiguated record
Julie Blanchard
Also filed as: BLANCHARD JULIE
7 granted patents·5 pending applications·45 citations·filing 1999–2018
84Inventor score
Files withROBIN JEAN PIERRE4STRAGEN PHARMA S A2CHEMGENEX PHARMACEUTICALS INC1IVAX INT GMBH1ONCOPHARM CORP1
Top patents by PatentIndex Score
12 records- 0179US7169774B2Cephalotaxane derivatives and their processes of preparation and purificationSTRAGEN PHARMA S A·Filed 2004·Granted Jan 30, 2007·8 cites·18 claims
- 0278US7842687B2Cephalotaxane derivatives and their processes of preparation and purificationCHEMGENEX PHARMACEUTICALS INC·Filed 2006·Granted Nov 30, 2010·3 cites·29 claims
- 0378US6613900B2Cephalotaxane derivatives and process for their preparationONCOPHARM CORP·Filed 2001·Granted Sep 2, 2003·11 cites·44 claims
- 0477USRE45128ECephalotaxane derivatives and their processes of preparation and purificationIVAX INT GMBH·Filed 2012·Granted Sep 9, 2014·1 cites·35 claims
- 0568US6987103B2Treatment of chronic myelogenous leukmia, resistant or intolerant to ST1571, involving homoharringtonine alone or combined with other agentsSTRAGEN PHARMA S A·Filed 2003·Granted Jan 17, 2006·10 cites·25 claims
- 0654US6831180B1Cephalotaxane derivatives and process for their preparationSTRAGEN PHARMA SA·Filed 1999·Granted Dec 14, 2004·12 cites·10 claims
- 0754US2014343039A1Process for preparing cephalotaxine estersROBIN JEAN-PIERRE·Filed 2014·Application pending·0 cites
- 0844US10150776B2Harringtonines salts in the crystalline state and their use for the purification of the corresponding drug substanceROBIN JEAN PIERRE·Filed 2014·Granted Dec 11, 2018·0 cites·17 claims
- 0944US2012022250A1Process for preparing cephalotaxine estersROBIN JEAN-PIERRE·Filed 2010·Application pending·0 cites
- 1039US2004186095A1Highly purified and crystalline form of harringtonines their process of preparation by purification of crude alkaloids from natural synthetic or semi-synthetic sources allowing their use for blending in pharmaceutical composition particularly useful for treatment of cancer in using oral mode of administrationFiled 2003·Application pending·0 cites
- 1139US2019161493A1Novel harringtonines salts in the crystalline state, their use for the purification of the corresponding drug substance and as chemotherapeutic agents given alone or combined with radiotherapy or as immunomodulating agentsROBIN JEAN PIERRE·Filed 2018·Application pending·0 cites
- 1236US2002128258A1Therapeutical method involving subcutaneous administration of drugs containing cephalotaxine derivativesFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →